(Total Views: 801)
Posted On: 03/04/2021 7:05:40 PM
Post# of 154091
Quote:
KOIN 6 News asked him if he stood by earlier statements that the stock value could hit the triple digits. He said yes, adding that each one of the numerous clinical trials could result in hundreds of billions of dollars in revenue if they’re approved.
Nader Pourhassan, CEO of CytoDyn, talks with KOIN 6 News via Zoom on March 1, 2021.
“I’m being very conservative when I said three digit,” Pourhassan said.
Raally ??? Did NP said three days ago that 3 digits is conservative ??
I am sure he already knows the results of CD-12.
But I don't think this is "for real".
(2)
(0)
